Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2021-12-10 14:50 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Varghese, Hemanth Jacob
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$284,590
+28,459 vol $10.00 each |
46,459 | |
Filed 2021-12-10 14:49 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Varghese, Hemanth Jacob
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$621,398
+41,125 vol $15.11 each |
117,999 | |
Filed 2020-11-13 14:54 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Varghese, Hemanth Jacob
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$180,000
+18,000 vol $10.00 each |
18,000 | |
Filed 2020-11-13 14:54 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Varghese, Hemanth Jacob
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-11-13 12:45 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Varghese, Hemanth Jacob
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$186,720
+12,000 vol $15.56 each |
76,874 | |
Filed 2019-06-11 10:59 Tx date 2019-06-07 |
$HLS
HLS Therapeutics Inc. |
Varghese, Hemanth Jacob
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$361,832
+23,269 vol $15.55 each |
64,874 | |
Filed 2018-08-23 Tx date 2018-08-22 |
$HLS
HLS Therapeutics Inc. |
Varghese, Hemanth Jacob
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$180,185
+21,605 vol $8.34 each |
41,605 | |
Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Varghese, Hemanth Jacob
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
20,000 |